🔴🔴Effects of Sacubitril/Valsartan Across the Spectrum of Renal Impairment in Patients With #HF
#PARADIGM -HF

👥 1,910 (23% of total) with available data, 42%, 32%, and 26% were classi fied as low,
moderate, and high/very high KDIGO risk, respectively

👉 👥 with HFrEF,

#SELECT Is It All About the Weight Loss?

Responder analyses subject to bias as those losing weight on Rx often have greater adherence

Despite this, pts w limited weight loss or even weight gain had similar #MACE benefit

🔑 Don’t stop #GLP1RA for CV benefit even w/o weight loss

🔴Association of High-Density Lipoprotein Parameters and Risk of Heart Failure: A Multicohort Analysis

👥16,925 participants ➡️612 incident HF events (3.6%) ⏰11.4 years.
👉↗️ HDL-P was significantly associated with ↘️ HF risk
👉↗️ HDL-size was significantly associated with ↗️

#SELECT Kidney Outcomes now out in Nature Medicine with #ERA24 !

Sema 2.4mg ow
✅ 22% ⬇️ 5-point kidney composite outcome, driven by UACR reduction
✅ 0.75mL/min slowing in eGFR decline

Kidney protection evident even in lower risk pts without DM or CKD!

nature.com/articles/s4159…

🔴 Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes NEJM ‼️

👥3533
↘️24% lower in the semaglutide group 🆚placebo group
👉Results were similar for a composite of the kidney-specific components of the primary outcome & CV ☠️

🔥🔥Semaglutide ↘️

Seguimos desvelando que amig@s nos acompañaran!!! 🔝🔝🔝 de Asociación Cardiología Clínica SEC Cardiología Preventiva Asociación Insuficiencia Cardiaca Soc Esp Cardiología Alfonso Valle Julio Román Freixa Pamias Marta Cobo Marcos Sergio Raposeiras-Roubín Almudena Castro Conde Domingo Pascual-Figal Luis Rguez. Padial que os parece este nivelazo!!!!! ❤😊

Emotivo homenaje a Nicolás Manito (Nicolas Manito) por su aportación al trasplante y la insuficiencia cardiaca.

'Las ganas, el sentimiento de pertenencia y el compañerismo han sido los pilares de la Asociación de Insuficiencia Cardiaca (@ICardiacaSEC)'.

Alejandro Recio Luis Pulpon

🔴Utilidad de los biomarcadores en el trasplante cardiaco para predecir el pronóstico vía REC Publications Insuficiencia Cardiaca y Trasplante

👉En los 👥 sometidos a trasplante cardiaco, ↗️significativa de troponina T, NT-proBNP, Cr y ácido láctico se asocia a fallecimiento o FPI grave

👉NT-proBNP es el

Aortic Stenosis Management in Patients With Acute Hip Fracture
👉 Delayed HFx surgery 🟰 ↗️ risk of permanent disability and ☠️
👉Timely diagnosis of AS in the setting of HFx is key to a preoperative strategy.
👉multidisciplinary approach for AS and HFx management may ↘️ time to

How to tackle therapeutic inertia in #HFrEF . A scientific statement of the Heart Failure Association of the European Society of Cardiology

👉organizational set-up of heart failure care pathways,
👉tailored drug initiation/optimization strategies increasing the chance of successful implementation

Cardiólogo interesado en nuevas oportunidades laborales??

Revisa nuestra área de empleo y becas de la SVC

👉 Hospital de Denia
👉 Consorcio Hospital General Universitario de Valencia

svcardio.org/empleo

Os presentamos nuestro proyecto #atria .

📖 Protocolo de actuación en enfermedad vascular aterosclerótica de SVCardio

✔️ Con el aval de SEMERGEN | Médicos Atención Primaria y SVEDYN

👨‍🎓Coordinado por Alfonso Valle y Lorenzo Fácila

Con el patrocinio de Novartis España

👉 svcardio.org/atria

🔴Targeting the Substrate for Atrial Fibrillation

👉 As a therapeutic target for AF, atrial
cardiomyopathy is not addressed by
ablation.

👉Biological and clinical data identify
adjunctive approaches to AF management
that can improve outcomes.

JACC Journals 📁

M. Pilar López AstraZeneca Servicio de Urgencias HUBU Burgos NefroHUBU Maria Izquierdo Ortiz Badawi Hijazi Prieto Beatriz Fernandez Fernandez Marco Montomoli Jose Luis Górriz 18 de Mayo! 2 día 1a mesa de farmacoeconomía Alfonso Valle juan m buades fuster #JordiBover

Julia Seller Alfonso Valle María Luis Almenar Bonet GVA Sanitat Universitat València JR Team Fed. Nac. ALCER oficial INCLIVA Insuficiencia Cardiaca y Trasplante Raquel López Vilella Beatriz Fernandez Fernandez asedecia Román Freixa Pamias David Vivas Maria Jose Soler Jose Luis Górriz Marco Montomoli Carolina Ortiz David Arroyo NefroHUBU Emilio Sánchez Claudia Yuste Dr Jorge Rico Nefrologo. MD. FSLANH, PhD (c). Mónica Martínez juan m buades fuster 3a y última mesa: Síndrome cardiorenal. Dr Jorge Rico Nefrologo. MD. FSLANH, PhD (c). Gregorio Romero-González Alfonso Valle #MarisaCrespo

Ya listos para nuestro conversatorio. Rodeado de grandes maestros . K + Leaders summit 2024. Barcelona 🇪🇸Alfonso Valle Gregorio Romero-González Marisa Crespo Leiro .

💉Inclisiran administration potently and durably lowers LDL-C over an extended-term follow-up: #ORION -8 trial

👥 3274
⏰Mean cumulative exposure to inclisiran (including parent trials) was 3.7 years; maximum exposure was 6.8 years

👉💉inclisiran, 78.4% of 👥 achieved

🔴Role of anti-obesity drugs in heart failure regardless of ejection fraction

👉 Pathophysiology of obesity phenotype of heart failure
with preserved ejection fraction

📁 onlinelibrary.wiley.com/doi/full/10.10…